132 related articles for article (PubMed ID: 18425078)
21. [Expression and significance of Smad2/3 and HPV16 E7 in cervical intraepithelial neoplasia and cervical carcinoma].
Tian Y; Wu P; Luo AY; Xi L; Zhou JF; Ma D
Ai Zheng; 2007 Sep; 26(9):967-71. PubMed ID: 17927854
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE; Nicolás FJ; Hill CS
Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
[TBL] [Abstract][Full Text] [Related]
24. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.
Wu MZ; Yuan YC; Huang BY; Chen JX; Li BK; Fang JH; Zhuang SM
Signal Transduct Target Ther; 2021 Nov; 6(1):395. PubMed ID: 34785655
[TBL] [Abstract][Full Text] [Related]
25. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
[TBL] [Abstract][Full Text] [Related]
28. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer.
Stojnev S; Krstić M; Čukuranović Kokoris J; Conić I; Petković I; Ilić S; Milosević-Stevanović J; Veličković LJ
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31238579
[No Abstract] [Full Text] [Related]
30. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
31. Expression and localization of Smad2 and Smad4 proteins in the porcine ovary.
Xing N; Liang Y; Gao Z; He J; He X; Li H; Dong C
Acta Histochem; 2014 Oct; 116(8):1301-6. PubMed ID: 25190106
[TBL] [Abstract][Full Text] [Related]
32. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ
Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334
[TBL] [Abstract][Full Text] [Related]
33. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
Banz-Jansen C; Münchow B; Diedrich K; Finas D
Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between Expression of TGF-β1, Smad2, Smad4 and Prognosis
of Patients with Resected Non-small Cell Lung Cancer].
Xie M; He C; Wei S
Zhongguo Fei Ai Za Zhi; 2015 Sep; 18(9):543-8. PubMed ID: 26383977
[TBL] [Abstract][Full Text] [Related]
35. MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma.
Maesawa C; Tamura G; Nishizuka S; Iwaya T; Ogasawara S; Ishida K; Sakata K; Sato N; Ikeda K; Kimura Y; Saito K; Satodate R
Jpn J Cancer Res; 1997 Apr; 88(4):340-3. PubMed ID: 9197523
[TBL] [Abstract][Full Text] [Related]
36. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
39. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.
Xie W; Mertens JC; Reiss DJ; Rimm DL; Camp RL; Haffty BG; Reiss M
Cancer Res; 2002 Jan; 62(2):497-505. PubMed ID: 11809701
[TBL] [Abstract][Full Text] [Related]
40. An N-terminally truncated Smad2 protein can partially compensate for loss of full-length Smad2.
Das D; Randall RA; Hill CS
Biochem J; 2009 Jan; 417(1):205-12. PubMed ID: 18764783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
